Reference curves for CD4 T-cell count response to combination antiretroviral therapy in HIV-1-infected treatment-naïve patients-Reference-Cited by-同舟云学术

Reference curves for CD4 T-cell count response to combination antiretroviral therapy in HIV-1-infected treatment-naïve patients

Published:2016-09-14 Issue:1 Volume:18 Page:33-44
ISSN:1464-2662
Container-title:HIV Medicine
language:en
Short-container-title:HIV Med

Author:

Bouteloup V¹²³,Sabin C⁴,Mocroft A⁴,Gras L⁵,Pantazis N⁶,Le Moing V⁷,d'Arminio Monforte A⁸,Mary-Krause M⁹,Roca B¹⁰,Miro JM¹¹,Battegay M¹²,Brockmeyer N¹³,Berenguer J¹⁴,Morlat P²¹⁵,Obel N¹⁶,De Wit S¹⁷,Fätkenheuer G¹⁸,Zangerle R¹⁹,Ghosn J²⁰²¹,Pérez-Hoyos S²²²³,Campbell M²⁴,Prins M²⁵²⁶,Chêne G¹²³²⁷,Meyer L²⁸²⁹,Dorrucci M³⁰,Torti C³¹,Thiébaut R²³²⁷,

Affiliation:

1. CIC 1401; CHU de Bordeaux; Bordeaux France

2. INSERM U1219 - Centre Inserm Bordeaux Population Health; Université de Bordeaux; Bordeaux France

3. ISPED; Centre INSERM U1219-Bordeaux Population Health; Université de Bordeaux; Bordeaux France

4. Research Department of Infection & Population Health; UCL; London UK

5. Stichting HIV Monitoring; Amsterdam The Netherlands

6. Department of Hygiene, Epidemiology & Medical Statistics; Athens University Medical School; Athens Greece

7. Montpellier University; Montpellier France

8. Infectious Diseases Unit; Department of Health Sciences; San Paolo University Hospital; Milan Italy

9. INSERM; Institut Pierre Louis d'épidémiologie et de Santé Publique (IPLESP UMRS 1136); UPMC Univ Paris 06; Sorbonne Universités; F-75013 Paris France

10. Hospital General of Castellon; Castellón Spain

11. Infectious Diseases Service. Hospital Clinic - IDIBAPS; University of Barcelona; Barcelona Spain

12. Division of Infectious Diseases and Hospital Epidemiology; Department of Clinical Research; University Hospital of Basel; Basel Switzerland

13. Department of Dermatology; Venerology - Center for Sexual Health and Medicine; Ruhr-Universität Bochum; Bochum Germany

14. Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM); Hospital General Universitario Gregorio Marañón; Madrid Spain

15. Service de Médecine Interne et Maladies Infectieuses; Hôpital Saint-André; Bordeaux France

16. Department of Infectious Diseases; Copenhagen University Hospital; Copenhagen Denmark

17. Department of Infectious Diseases; St Pierre University Hospital; Université Libre de Bruxelles; Brussels Belgium

18. Department of Internal Medicine; University of Cologne and German Centre for Infection Research (DZIF); Cologne Germany

19. Medical University Innsbruck; Innsbruck Austria

20. APHP; Unité Fonctionnelle de Thérapeutique en Immuno-Infectiologie; Centre Hospitalier Universitaire Hôtel Dieu; Paris France

21. Faculté de Médecine Site Necker; Sorbonne Paris Cité; Université Paris Descartes; EA 7327 Paris France

22. Vall d'Hebrón Institut de Recerca (VHIR); Barcelona Spain

23. Universitat Autònoma de Barcelona; Barcelona Spain

24. CHIP; Department of Infectious Diseases; Rigshospitalet; University of Copenhagen; Copenhagen Denmark

25. Division of Infectious Diseases; Department of Internal Medicine; Center for Infection and Immunity Amsterdam (CINIMA); Academic Medical Center; Amsterdam The Netherlands

26. Department of Infectious Diseases; Public Health Service; Amsterdam The Netherlands

27. CHU de Bordeaux; Pole de Sante Publique; Service d'Information Medicale; F-33000 Bordeaux France

28. INSERM; U1018; Epidemiology of HIV, Reproduction, Paediatrics; CESP; University Paris-Sud; Paris France

29. Department of Public Health and Epidemiology; Bicêtre Hospital; AP-HP; Le Kremlin Bicêtre; Paris France

30. Department of Infectious; Parasitic and Immune-mediated Diseases; Istituto Superiore di Sanità; Rome Italy

31. Unit of Infectious and Tropical Diseases; Department of Medical and Surgical Sciences; University “Magna Graecia”; Catanzaro Italy

Funder

HIV Monitoring Foundation, The Netherlands;

Gilead Sciences

Novartis

Instituto de Salud Carlos III

Fundación para la Investigación y la Prevención del Sida en España

Ministerio de Sanidad, Servicios Sociales e Igualdad

National Institutes of Health

NEAT

Seventh Framework Programme

Abbvie

Bristol-Myers Squibb Foundation

Merck

Cubist

Publisher

Wiley

Subject

Pharmacology (medical),Infectious Diseases,Health Policy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hiv.12389/fullpdf

Reference32 articles.

1. Trends and determinants of severe morbidity in HIV-infected patients: the ANRS CO3 Aquitaine Cohort, 2000-2004;Bonnet;HIV Med,2007

2. Life expectancy living with HIV: recent estimates and future implications;Nakagawa;Curr Opin Infect Dis,2013

3. British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012 (Updated November 2013. All changed text is cast in yellow highlight.);Williams;HIV Med,2014

4. Laboratory control values for CD4 and CD8 T lymphocytes. Implications for HIV-1 diagnosis;Bofill;Clin Exp Immunol,1992

5. The incidence of AIDS-defining illnesses at a current CD4 count ≥ 200 cells/μL in the post-combination antiretroviral therapy era;Mocroft;Clin Infect Dis,2013

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterization and Determinants of Long-Term Immune Recovery Under Suppressive Antiretroviral Therapy;JAIDS Journal of Acquired Immune Deficiency Syndromes;2024-05-01

2. Strategies for HIV-1 suppression through key genes and cell therapy;Frontiers in Medicine;2023-11-29

3. Role of CD4 count estimation in the era of HIV-1 viral load among PLHIV;Indian Journal of Medical Microbiology;2023-11

4. Enabling CAR T‐cell therapies for HIV‐positive lymphoma patients – A call for action;HIV Medicine;2023-06-15

5. Low pre-ART CD4 count is associated with increased risk of clinical progression or death even after reaching 500 CD4 cells/μL on ART;PLOS ONE;2023-03-30